Okie_老虎社区_美港股上老虎

mllee1108
2021-07-17

Okie

Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content

Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo

Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":179206410,"tweetId":"179206410","gmtCreate":1626527945330,"gmtModify":1631889915881,"author":{"id":3585475178971932,"idStr":"3585475178971932","authorId":3585475178971932,"authorIdStr":"3585475178971932","name":"mllee1108","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Okie</p></body></html>","htmlText":"<html><head></head><body><p>Okie</p></body></html>","text":"Okie","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/179206410","repostId":2152168563,"repostType":4,"repost":{"id":"2152168563","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626489317,"share":"https://www.laohu8.com/m/news/2152168563?lang=&edition=full","pubTime":"2021-07-17 10:35","market":"us","language":"en","title":"Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content","url":"https://stock-news.laohu8.com/highlight/detail?id=2152168563","media":"T-Reuters","summary":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo","content":"<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152168563","content_text":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}